OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Molecular Diagnostics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence	93
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer	76
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features	69
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling	52
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study	48
Cost analyses for malaria molecular diagnosis for research planners in India and beyond	37
What makes a « good » companion diagnostic in thoracic oncology?	35
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment	34
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects	32
Polygenic and Network-based studies in risk identification and demystification of cancer	31
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis	30
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer	30
Nuclease activity: an exploitable biomarker in bacterial infections	29
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer	29
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination	29
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA	28
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome	27
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology	27
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma	26
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma	24
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?	23
The MALAT1-breast cancer interplay: insights and implications	23
The current and future applications of in situ hybridization technologies in anatomical pathology	23
Can multiplex molecular panels of microbial pathogens transform respiratory care in critically ill patients?	22
Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma	22

Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study	21
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease	21
Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations	21
Clinical application of noninvasive prenatal testing in twin pregnancies: a single-center experience	21
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward	20
How mitochondrial DNA complicates pre-implantation genetic screening and management	19
Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis	18
Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers	18
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma	18
Cell avidity in CAR-T cell therapy	17
Early Identification of Fungal and Mycobacterium Infections in Pulmonary Granulomas Using Metagenomic Next-Generation Sequencing on Formalin fixation and paraffin embedding tissue	17
Mutation profiling of chronic myeloproliferative neoplasms: improving clinical-molecular prognostic models	17
The clinical importance of high-sensitivity cardiac troponin measurements for risk prediction in non-cardiac surgery	17
Optimization of time interval for the measurement of plasma lipids for cardiovascular disease risk assessment	16
Discovery of potential biomarkers for osteoporosis diagnosis by individual omics and multi-omics technologies	16
Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond	16
Point-of-care isothermal nucleic acid amplification tests: progress and bottlenecks for extraction-free sample collection and preparation	16
The promise of liquid biopsies in prostate cancer: a potential point-of-care modality for precision oncology	16
Molecular predictors of metastasis in patients with prostate cancer	16
Molecular diagnostic criteria of myeloproliferative neoplasms	16
Efficient screening strategies for severe combined immunodeficiencies in newborns	15
The challenges and potential in developing microRNA associated with regeneration as biomarkers to improve prognostication for liver failure syndromes and hepatocellular carcinoma	15
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis	15
The integration of biomarkers and patient-reported outcomes improves prediction of interstitial cystitis syndrome	15
LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis	14
Comprehensive genomic profiling: a public health system perspective	14
Early diagnostics of fibromyalgia: an overview of the challenges and opportunities	14
Regulation of biomarker analysis: what can be translated in the clinic?	14
Analytical validation of urine ALCAM ELISA as a test for lupus nephritis	14
Extracellular vesicles as source of biomarkers in hematological malignancies: looking towards clinical applications	13
Cytokines as biomarkers of Huntington’s disease progression	13
Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis	13
Molecular deciphering of melanoma: advances and challenges of neoadjuvant and perioperative treatment	13
Cystic echinococcosis microRNAs as potential noninvasive biomarkers: current insights and upcoming perspective	13
Biomarkers of sleep-wake disturbance as predictors of cognitive decline and accelerated disease progression	12
Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease	12
Diagnostic approaches for dengue infection	12
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlook	12
Association betweenCDH1methylation and esophageal cancer risk: a meta-analysis and bioinformatics study	12
Faster infection diagnostics for intensive care unit (ICU) patients	12
Association between polymorphisms in TLR3 , TICAM1 and IFNA1 genes and covid-19 severity in Southern Brazil	12
An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure	12
Intraoperative detection of axillary metastasis of breast cancer using nucleic acid amplification methods: review of advantages and limitations	12
Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios	11
Decoding pancreatic cancer: key risk factors across genetics and lifestyle	11
Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa	11
Unraveling the future: hot topics shaping molecular diagnostics today	11
Mortality prediction of patients with spontaneous intracerebral hemorrhage by serum soluble Fas ligand concentrations	11
Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials	11
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery	11

Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring	11
From detection to action: new diagnostic insights into antifungal resistance	10
MicroRNA dysregulation in schistosomiasis-induced hepatic fibrosis: a systematic review	10
Association between NUDT17 polymorphisms and breast cancer risk	10
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers	10
COVID-19 diagnosis: lessons to learn and hints for preparedness	10
Current and emerging technologies to develop Point-of-Care Diagnostics in medical mycology	10
Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis	10
hTERT rs2735940 polymorphism influences lung cancer risk and overall survival in lung cancer patients undergoing platinum-based doublet chemotherapy	10
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors	10
Genetic-based diagnostics of Parkinson’s disease and other Parkinsonian syndromes	10
Molecular determination of insect venom allergies	9
Advances in pediatric sepsis biomarkers - what have we learnt so far?	9
The role of fecal biomarkers in individuals with inflammatory bowel disease	9
How our molecular understanding of the pathogenesis of Mycobacterium ulcerans infection can improve diagnosis of Buruli ulcer	9
Noninvasive prenatal screening in southeast China: clinical application and accuracy evaluation	9
JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence	9
Highlighting and addressing barriers to widespread adaptation of HIV self-testing in the United States	9
Variants of KLF5 and KLF12 were related to endometrial cancer risk in the Chinese population	8
Development and validation of a nomogram for the prediction of metabolic syndrome in polycystic ovary syndrome in a Chinese population	8
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention	8
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers	8
Global polymorphism of Plasmodium falciparum histidine rich proteins 2/3 and impact on malaria rapid diagnostic test detection: a systematic review and meta-analysis	8
Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases	8
Statistical determination of cancer biomarkers: moving forward clinically	8
Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic review	8
Combining oral fluid aMMP-8, calprotectin, and CCAAs in dental panoramic radiography for periodontal disease and systemic disease risk assessment: a point-of-care diagnostic approach	8
Recent developments in wearable & non-wearable point-of-care biosensors for cortisol detection	8
Neuroimaging in hereditary spastic paraplegias: from qualitative cues to precision biomarkers	8
Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer	8
Towards improved point-of-care (POC) testing for patients with suspected sepsis: POC tests for host biomarkers and possible microbial pathogens	8
Future potential of metagenomics in microbiology laboratories	8